Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine-Reference-Cited by-同舟云学术

Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine

Published:2022-08-23 Issue:6 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Tanner Richard¹^ORCID,Starr Neasa¹,Perez‐Garcia Carlos Nicolas¹,Chan Grace²,Dempsey Eimear¹,Heffernan Emma³,Lynch Breda²,Hannan Margaret M²⁴,Joyce Emer¹⁴

Affiliation:

1. Department of Cardiology Mater Misericordiae University Hospital Dublin Ireland

2. Department of Microbiology Mater Misericordiae University Hospital Dublin Ireland

3. Department of Immunology Mater Private Hospital Dublin Ireland

4. School of Medicine University College Dublin Dublin Ireland

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13935

Reference17 articles.

1. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes

2. Outcomes of Coronavirus Infectious Disease -19 (COVID-19) in Solid Organ Transplant Recipients

3. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

4. Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients – a prospective cohort study

5. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Measures to Increase Immunogenicity of SARS-CoV-2 Vaccines in Solid Organ Transplant Recipients: A Narrative Review;Vaccines;2023-11-25